Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

RUMA clarifies its position on antibiotics
cows
RUMA does not support routine preventative use of antibiotics in the place of better husbandry or farm management.
Position paper addresses "inaccurate assertions"

A "wide-ranging" position paper has been released by the Responsible Use of Medicines in Agriculture Alliance (RUMA), to clarify its position on antibiotic resistance and the use of antibiotics in farming.

The paper also states that it aims to address "inaccurate assertions" made by the Alliance to Save our Antibiotics (ASOA).

Resistance is a hotly debated topic, with the Prime Minister recently commissioning a review to help address the problem.

Last year, the UK's chief medical officer said: "Antibiotic resistance is one of the greatest threats to modern health and we face a future without cures for infection if antibiotics are not used responsibly."

RUMA says it does not support routine preventative use of antibiotics in the place of better husbandry or farm management.

The position paper states that scientific evidence suggests antibiotic resistance in humans is largely down to overuse or misuse in human as opposed to veterinary medicine.

A report by the House of Commons Science and Technology Committee, cited in RUMA's paper,  states that "there is circumstantial evidence that antimicrobial resistance can be transmitted from animal pathogens to human pathogens although the evidence base in incomplete". (Ensuring Access to Working Antimicrobials, paragraph 51).

RUMA says it supports the committee's call for further research in this area and highlights more recent research which found resistant bacteria are genetically different in animals and humans.

RUMA added that there is "no clinical crisis in animal medicine" and antibiotic treatments continue to work.

The alliance called on ASOA and others licensing organic production to allow antibiotics to be used responsibly for the benefit of animal welfare.

Removing certain antibiotics from animal use with put pressure on the remaining classes, thereby increasing, rather than reducing, the risk of resistance developing, RUMA says.

Animal welfare must also be considered. The paper states: "We need to consider very carefully the consequences of of reducing necessary antibiotic use in animals, which can have serious animal welfare/health implications, for possibly no benefit to reducing resistance in humans."

However, RUMA says there must be no complacency about antibiotic use in animals and medicines must be used responsibly in agriculture to prevent problems in animal or human medicine.

Visit RUMA's website for the full paper: http://www.ruma.org.uk/news/20140408.htm

Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.